Novartis Investigative Site

Kamakura, Kanagawa 247-8533

0 studies enrolling now · 2 studies all time

What they study most

Muscle Wasting (Atrophy) After Hip Fracture Surgery, Rheumatoid Arthritis

Studies at this site

• Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery — Completed
• Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents — Completed